The subject of patent applications drafted, patent applications prosecuted, opinions rendered on, and/or licensing agreements worked on include inventions in synthetic organic chemistry; small-molecular drugs design; pharmaceutics (including CNS actives, oxazolidinone antibiotics, pyrimidine biosynthesis inhibitors, analgesics, ADHD formulations, NMDA antagonists, JAK1 inhibitors, testosterone gels, nasal spray, controlled release formulations, transdermal patch, apparatus for combinatorial synthesis, polymorphism, supercritical fluids, milling apparatus, suspensions and emulsions, paragraph IV certification support); natural product isolation; medical devices (inhalers, stents); biotechnology (sequences, dendritic cell cancer therapy, biochip technology); nanotechnology; thermoset polymers; chromatography; analytical techniques; materials engineering; heterogeneous catalysis; crystallization; ink jets; surfactants; solar cells; reaction design; piezoelectric ceramics; zeolites; algaecides; carbon black; films; and communication devices.

Prior to launching his own firm, Peter was a member of the Philadelphia office of a large East Coast general practice law firm, where he prepared opinions and performed due diligence analyses of acquisition targets in small molecules and biopharma businesses for a major pharmaceutical client. He also prepared and prosecuted U.S. patent applications, and directed prosecution of international patent applications. Further, he aided with pharmaceutical litigation by drafting pleadings on behalf of a large pharmaceutical company.

Peter also spend 6 years at a medium-sized intellectual property boutique as a patent agent and later as an associate, where he prepared, and prosecuted U.S. patent applications and directed prosecution of international patent applications; prosecuted and supervised international prosecution of a 240-application global patent portfolio for iloperidone (now Fanapt®); advised business decision-makers in Fortune 500 companies on global patent portfolio strategies; prepared reports on patent landscape prior to client’s entry into new business markets; was the working attorney on a winning patent interference case; and supported trademark opposition proceedings, and patent litigation. Peter also spend 6 years at a medium-sized intellectual property boutique as a patent agent and later as an associate, where he prepared, and prosecuted U.S. patent applications and directed prosecution of international patent applications; prosecuted and supervised international prosecution of a 240-application global patent portfolio for iloperidone (now Fanapt®); advised business decision-makers in Fortune 500 companies on global patent portfolio strategies; prepared reports on patent landscape prior to client’s entry into new business markets; was the working attorney on a winning patent interference case; and supported trademark opposition proceedings, and patent litigation.

Peter worked for over five years as a Senior Technical Specialist and a Patent Liaison for ICI Polyurethanes and Huntsman Polyurethanes. As a Patent Liaison he interacted with patent counsel and inventors; performed patent portfolio/business strategy formulation; and provided legal opinion and due diligence support. As a product development professional in polymer chemistry, his work included experimental design, directing screening and optimization of polymer formulation, developing new methods, and advising on business strategy.

J.D.: Rutgers University School of Law– Camden.

Ph.D. - Chemistry: University of Wisconsin–Madison. His research work on resulted in 4 academic papers and several posters. He also taught undergraduate chemistry for which he was awarded Citation for Teaching Excellence.

M.B.A. - Finance, Investment and Banking: University of Wisconsin–Madison.

B.S. - Chemistry: University of California–Berkeley. During his school at Berkeley, Peter conducted 4 semesters of independent research in bio-inorganic chemistry, and taught introductory Astronomy.